Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · IEX Real-Time Price · USD
2.130
+0.060 (2.90%)
At close: Mar 28, 2024, 3:49 PM
2.250
+0.120 (5.63%)
After-hours: Mar 28, 2024, 7:57 PM EDT

Bone Biologics Stock Forecast

BBLG's stock price has decreased by -96.11% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Bone Biologics stock has a target of 540, which predicts an increase of 25,252.11% from the current stock price of 2.13.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $540 $540 $540 $540
Change +25252.1% +25252.1% +25252.1% +25252.1%
* Price targets were last updated on Apr 13, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for Bone Biologics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '23Feb '23Mar '23Apr '23
Strong Buy 1111
Buy 0000
Hold 0000
Sell 0000
Strong Sell 0000
Total 1111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
EF Hutton
EF Hutton
Strong Buy
Reiterates
$540
Strong Buy Reiterates $540 +25,252.11% Apr 13, 2023
EF Hutton
EF Hutton
Strong Buy
Reiterates
$540
Strong Buy Reiterates $540 +25,252.11% Apr 3, 2023
EF Hutton
EF Hutton
Strong Buy
Initiates
$540
Strong Buy Initiates $540 +25,252.11% Oct 18, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-30.73
from -34.01
EPS Next Year
-32.19
from -30.73
Year 2019202020212022202320242025
Revenue
-------
Revenue Growth
-------
EPS
-282.00-151.20-84.00-31.15-34.01-30.73-32.19
EPS Growth
-------
No. Analysts -----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20242025
High - -
Avg - -
Low - -

EPS Forecast

EPS 20242025
High -31.64 -33.14
Avg -30.73 -32.19
Low -29.53 -30.93

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.